<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新康界 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T20:22:39+08:00</updated>
  <subtitle>中康资讯旗下品牌，中国领先的医药健康产业财经新媒体。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>余文心：一名医药分析师眼中的中国医药产业十年</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/FX2AhIjvbo2ZU4leFE-cug</id>
    <link href="https://mp.weixin.qq.com/s/FX2AhIjvbo2ZU4leFE-cug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大健康产业投资并购动态周报Vol.26</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/tYwyrMXdgENg7IM6CnpE-A</id>
    <link href="https://mp.weixin.qq.com/s/tYwyrMXdgENg7IM6CnpE-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>明年医药板块怎么走？磨底+结构性行情</title>
    <updated>2020-11-17T19:07:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/XEbKuHpjibAwJbKjbKEe9g</id>
    <link href="https://mp.weixin.qq.com/s/XEbKuHpjibAwJbKjbKEe9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判：中国特色“医保”悬崖！</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/p9FnoNB9DfsbtOt5iwKegw</id>
    <link href="https://mp.weixin.qq.com/s/p9FnoNB9DfsbtOt5iwKegw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首宣！药品监管科学&amp;药物创新研讨会——暨首届《中国食品药品监管》杂志学术年会会议通知</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/HCXt_Ly7578CQ_LPT59TQA</id>
    <link href="https://mp.weixin.qq.com/s/HCXt_Ly7578CQ_LPT59TQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：京东健康通过港交所聆讯，民族药、中药饮片可纳入省级医保范围​</title>
    <updated>2020-11-16T19:08:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/1NrB1DJ6UEB-3uM0iaUs0g</id>
    <link href="https://mp.weixin.qq.com/s/1NrB1DJ6UEB-3uM0iaUs0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从进博会和三季报看17家跨国药企在中国市场的创新加码</title>
    <updated>2020-11-14T14:21:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/R-CW53CYGVsAdHPbbEDhTQ</id>
    <link href="https://mp.weixin.qq.com/s/R-CW53CYGVsAdHPbbEDhTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：处方药有望网售，国药新冠灭活疫苗好于预期</title>
    <updated>2020-11-14T14:21:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/p4UWK9WhxO7kd2U7P3NL_A</id>
    <link href="https://mp.weixin.qq.com/s/p4UWK9WhxO7kd2U7P3NL_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“兽爷”，创新药研发不是这么看的</title>
    <updated>2020-11-13T10:42:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/jareA45A0TSz1LyEoZ4JjA</id>
    <link href="https://mp.weixin.qq.com/s/jareA45A0TSz1LyEoZ4JjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>网售处方药开闸在即，重磅征求意见稿来了！</title>
    <updated>2020-11-13T10:42:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/OD8x5FD7vfBZAKwkZ9oCYw</id>
    <link href="https://mp.weixin.qq.com/s/OD8x5FD7vfBZAKwkZ9oCYw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞免疫疗法：盛名之下，其实难副？</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/naCRa6hvlCHnHmuzApoBng</id>
    <link href="https://mp.weixin.qq.com/s/naCRa6hvlCHnHmuzApoBng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曾受邀去AZ做分享！余文心的医药十年报告讲了什么？今晚8点揭晓</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Wlg_XN_AjXhcW40Wrmj8dA</id>
    <link href="https://mp.weixin.qq.com/s/Wlg_XN_AjXhcW40Wrmj8dA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高瓴等巨头重投2千亿 催生万亿级健康公司</title>
    <updated>2020-11-12T19:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/PWBgo0L5zaxVqQR6ApKRJA</id>
    <link href="https://mp.weixin.qq.com/s/PWBgo0L5zaxVqQR6ApKRJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>近日药闻：辉瑞新冠疫苗三期临床有效率达90%，艾力斯上市科创板</title>
    <updated>2020-11-11T19:07:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/WdT2F7IGbH5pqH6GNnTXxw</id>
    <link href="https://mp.weixin.qq.com/s/WdT2F7IGbH5pqH6GNnTXxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>倒计时1天，余文心的直播课程即将上线！</title>
    <updated>2020-11-11T19:07:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/eW9pL2XJExEPn6bF9TvcIg</id>
    <link href="https://mp.weixin.qq.com/s/eW9pL2XJExEPn6bF9TvcIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿卡波糖中标后的糖尿病用药市场现状</title>
    <updated>2020-11-11T19:07:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/WCfhDsUu1ZMDk4tugi6ruQ</id>
    <link href="https://mp.weixin.qq.com/s/WCfhDsUu1ZMDk4tugi6ruQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从高值耗材集采后迈瑞医疗的大跌说起</title>
    <updated>2020-11-10T20:04:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/B25YfwgrG-IclVfrR14r-A</id>
    <link href="https://mp.weixin.qq.com/s/B25YfwgrG-IclVfrR14r-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药A+H股市值变迁，如何寻找十年十倍医药股？</title>
    <updated>2020-11-10T20:04:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/UVmTAK2JTuY7lr67yVCpNQ</id>
    <link href="https://mp.weixin.qq.com/s/UVmTAK2JTuY7lr67yVCpNQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大健康产业投资并购动态周报Vol.25</title>
    <updated>2020-11-10T20:04:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/Rr2gYWeRFB9Eu395jygLew</id>
    <link href="https://mp.weixin.qq.com/s/Rr2gYWeRFB9Eu395jygLew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年度策略报告| “双循环”背景下，“创新升级+进口替代”引领医药大时代</title>
    <updated>2020-11-10T20:04:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/5RsHli6BnZd3Wmk3uhGO9g</id>
    <link href="https://mp.weixin.qq.com/s/5RsHli6BnZd3Wmk3uhGO9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>